top of page

IMR

Imricor Medical Systems Inc

Healthcare Equipment and Supplies

·

Healthcare

19

comments

3

fund managers

past 90 days

About Imricor Medical Systems Inc

Imricor Medical Systems, Inc., founded in 2006 and headquartered in Burnsville, MN, designs, manufactures, and distributes MRI-compatible medical devices for cardiac catheter ablation. Its product portfolio includes the Advantage-MR EP Recorder/Stimulator, the Vision-MR Ablation Catheter for type I atrial flutter treatment, and the Vision-MR Dispersive Electrode, which reduces eddy currents during MR scanning. Additionally, the company conducts contract research and licenses its proprietary intellectual property for use in implantable devices.

Commentary Volume

19

Comments

3

Fund managers

0

Past 90 days

SOURCE

ACTION

COMMENT PREVIEW

FUND MANAGER

DATE

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Loading...

.

​Loading...

Loading...

Loading...

Loading...

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Report a problem

Loading...

.

Loading...

Loading...

Loading...

Loading...

14 Mar 2025

ic

Ipsum Capital

"Lorem ipsum dolor sit amet...

Q4 Letter

14 Mar 2025

ic

Dolor Investments

"Lorem ipsum dolor sit amet...

Q4 Letter

🔒 21 more comments from 10 sources

Unlock full access

§ Important Notice

The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Commentary

Sector

Healthcare

Market cap

$627M

Fund managers

3 managers

First covered

31 Jan 2024

Last updated

31 Mar 2026

Company Details

Related Themes

ic

Ipsum Capital

6 comments

ic

Amet Funds

4 comments

ic

Dolor

3 comments

Top Investors Covering MIN

§ Reminder

The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Frequently asked questions about Imricor Medical Systems Inc (ASX:IMR)

Frequently asked questions

Who is investing in Imricor Medical Systems Inc (ASX:IMR)?

Fund managers including Saville Capital, Wilson Asset Management and Investors Mutual Limited have invested in Imricor Medical Systems Inc (ASX:IMR).

What is the short interest in Imricor Medical Systems Inc (ASX:IMR)?

The short interest in Imricor Medical Systems Inc (ASX:IMR) is 0.12% which makes it the 397th most shorted stock on the ASX. Of the 320.9M shares that Imricor Medical Systems Inc has on issue, 382.8K have been sold short.

What does Imricor Medical Systems Inc (ASX:IMR) do?

Imricor Medical Systems, Inc., founded in 2006 and headquartered in Burnsville, MN, designs, manufactures, and distributes MRI-compatible medical devices for cardiac catheter ablation. Its product portfolio includes the Advantage-MR EP Recorder/Stimulator, the Vision-MR Ablation Catheter for type I atrial flutter treatment, and the Vision-MR Dispersive Electrode, which reduces eddy currents during MR scanning. Additionally, the company conducts contract research and licenses its proprietary intellectual property for use in implantable devices.

bottom of page